Outcomes of a trial of HIV-1 immunogen in patients with HIV infection

Journal of the American Medical Association

Volumn 285, Issue 17, 2001, Pages 2191-2195

  Dat, Nguyen V ^a   Gotch, Frances M ^b   Imami, Nesrina ^b   Goldberg, Billi ^c   Stricker, Raphael B ^d   Poretz, Donald M ^e,f   Lurie, Peter ^g   Wolfe, Sidney M ^g   Kahn, James O ^h   Lagakos, Stephen ⁱ  

^a ASG Inc   (United States)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c Dinitrochlorobenzene Study Group   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Infectious Diseases Physicians   (United States)

^g Public Citizen s Health Research Group   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aids vaccines; Clinical trials; Hiv infections; Hiv vaccines; Immunogens, synthetic; Randomized trials; Treatment outcome; Vaccines, synthetic

Indexed keywords

ANTIRETROVIRUS AGENT; FREUND ADJUVANT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ANTIGEN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HIV 1 IMMUNOGEN, INCOMPLETE FREUND'S ADJUVANT; HIV-1 IMMUNOGEN, INCOMPLETE FREUND'S ADJUVANT; IMMUNOLOGICAL ADJUVANT;

CELL COUNT; CLINICAL TRIAL; CYTOKINE PRODUCTION; DEMOGRAPHY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOTHERAPY; INFECTION CONTROL; LETTER; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS LOAD; CD4 LYMPHOCYTE COUNT; NOTE;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; VIRAL LOAD;

EID: 0035795605     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.17.2191     Document Type: Letter

References (0)